ARMISTICE CAPITAL LLC 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-12-21 5:07 pm Purchase | 2020-12-11 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 26,666,680 7.700% | 25,851,934 (+3173.01%) | Filing |
| 2020-04-29 5:29 pm Sale | 2020-04-27 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 814,746 0.400% | -9,403,096 (-92.03%) | Filing |
| 2020-04-08 4:21 pm Purchase | 2020-03-20 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 10,217,842 5.300% | 217,840 (+2.18%) | Filing |
| 2020-03-13 4:57 pm Sale | 2020-03-10 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 10,000,002 9.100% | -14,724,278 (-59.55%) | Filing |
| 2020-02-20 2:43 pm Purchase | 2020-02-14 | 13D | Aytu BioPharma, Inc. AYTU | ARMISTICE CAPITAL LLC | 24,724,280 40.000% | 7,966,896 (+47.54%) | Filing |